{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T20:29:04Z","timestamp":1778099344295,"version":"3.51.4"},"reference-count":45,"publisher":"Georg Thieme Verlag KG","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Low-density lipoprotein-cholesterol reduction showed a strong reduction of cardiovascular (CV) event rates in CV disease. However, the residual risk of future CV events remains high, which especially extends to peripheral arterial disease (PAD). Nuclear magnetic resonance (NMR) spectroscopy offers a novel method for analysis of the lipoprotein spectrum. This study investigates lipoprotein subclasses using NMR spectroscopy and assesses implications for long-term survival in PAD. NMR spectroscopy was performed by Nightingale Inc., in 319 patients with stable PAD and well-controlled CV risk factors. Patients were followed-up for 10 years. During that period, 123 patients (38.5%) died, of those 68 (21.3%) were defined as CV deaths. Outcome data were analyzed by the Kaplan\u2013Meier method and multivariable Cox-regression for lipoprotein particles. Small and medium high-density lipoprotein-particles (S-HDL-P and M-HDL-P) showed a significant inverse association with all-cause mortality in Cox-regression analyses after multivariable adjustment (S-HDL-P, hazard ratio [HR]: 0.71, 95% confidence interval [CI]: 0.57\u20130.88; M-HDL-P, HR: 0.72, 95% CI: 0.58\u20130.90) for each increase of one standard deviation. In contrast, cholesterol-rich X-large HDL-particles (XL-HDL-P) showed a positive association with all-cause mortality (HR: 1.51, 95% CI: 1.20\u20131.89). Only the association between XL-HDL-P and CV death sustained multivariable adjustment (HR: 1.49, 95% CI: 1.10\u20132.02), whereas associations for S-HDL-P and M-HDL-P were attenuated (HR: 0.76, 95% CI: 0.57\u20131.01; HR: 0.80, 95% CI: 0.60\u20131.06). This study shows a novel association for a beneficial role of S-HDL-P and M-HDL-P but a negative association with higher cholesterol-rich XL-HDL-P for long-term outcome in well-treated patients with PAD. Thus, these results provide evidence that NMR-measured HDL particles identify patients at high CV residual risk beyond adequate lipid-lowering therapy.<\/jats:p>","DOI":"10.1055\/a-1827-7896","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T23:12:52Z","timestamp":1650323572000},"page":"1804-1813","source":"Crossref","is-referenced-by-count":4,"title":["High-Density Lipoprotein Particle Subclasses in Statin-Treated Patients with Peripheral Artery Disease Predict Long-Term Survival"],"prefix":"10.1055","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3225-9063","authenticated-orcid":false,"given":"Bernhard","family":"Zierfuss","sequence":"additional","affiliation":[{"name":"Division of Angiology, Department of Medicine 2, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9704-1452","authenticated-orcid":false,"given":"Clemens","family":"H\u00f6baus","sequence":"additional","affiliation":[{"name":"Division of Angiology, Department of Medicine 2, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten T.","family":"Herz","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Dialysis, Department of Medicine 3, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate","family":"Koppensteiner","sequence":"additional","affiliation":[{"name":"Division of Angiology, Department of Medicine 2, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Stangl","sequence":"additional","affiliation":[{"name":"Center for Pathobiochemistry and Genetics, Institute for Medical Chemistry, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerit-Holger","family":"Schernthaner","sequence":"additional","affiliation":[{"name":"Division of Angiology, Department of Medicine 2, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,6,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"290","author":"Authors\/Task Force Members","year":"2019","journal-title":"Atherosclerosis"},{"issue":"14","key":"ref2","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/eurheartj\/ehx566","article-title":"Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials","volume":"39","author":"K C Koskinas","year":"2018","journal-title":"Eur Heart J"},{"issue":"04","key":"ref3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)","volume":"137","author":"M P Bonaca","year":"2018","journal-title":"Circulation"},{"issue":"22","key":"ref4","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"G G Schwartz","year":"2018","journal-title":"N Engl J Med"},{"issue":"16","key":"ref5","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1001\/archinte.165.16.1896","article-title":"Risk factors for declining ankle-brachial index in men and women 65 years or older: the Cardiovascular Health Study","volume":"165","author":"M Kennedy","year":"2005","journal-title":"Arch Intern Med"},{"issue":"06","key":"ref6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1067\/mhj.2002.122871","article-title":"Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study","volume":"143","author":"J M Murabito","year":"2002","journal-title":"Am Heart J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"C Baigent","year":"2010","journal-title":"Lancet"},{"issue":"19","key":"ref8","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1001\/archinte.160.19.2934","article-title":"Determinants of peripheral arterial disease in the elderly: the Rotterdam study","volume":"160","author":"W T Meijer","year":"2000","journal-title":"Arch Intern Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths","volume":"370","author":"S Lewington","year":"2007","journal-title":"Lancet"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/01.CIR.88.3.837","article-title":"Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study","volume":"88","author":"A B Newman","year":"1993","journal-title":"Circulation"},{"issue":"24","key":"ref11","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"W E Boden","year":"2011","journal-title":"N Engl J Med"},{"issue":"13","key":"ref12","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","volume":"377","author":"L Bowman","year":"2017","journal-title":"N Engl J Med"},{"issue":"09","key":"ref13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/eurheartj\/eht571","article-title":"Mendelian randomization of blood lipids for coronary heart disease","volume":"36","author":"M V Holmes","year":"2015","journal-title":"Eur Heart J"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10557-018-06846-w","article-title":"High-density lipoprotein function and dysfunction in health and disease","volume":"33","author":"S T Chiesa","year":"2019","journal-title":"Cardiovasc Drugs Ther"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/eurheartj\/ehu264","article-title":"HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the Lipoprotein Investigators Collaborative","volume":"36","author":"S S Martin","year":"2015","journal-title":"Eur Heart J"},{"issue":"06","key":"ref16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jacc.2012.03.060","article-title":"High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis)","volume":"60","author":"R H Mackey","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.atherosclerosis.2016.06.010","article-title":"Small and medium sized HDL particles are protectively associated with coronary calcification in a cross-sectional population-based sample","volume":"251","author":"C Ditah","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.atherosclerosis.2016.01.012","article-title":"High-density lipoprotein subclass measurements improve mortality risk prediction, discrimination and reclassification in a cardiac catheterization cohort","volume":"246","author":"R W McGarrah","year":"2016","journal-title":"Atherosclerosis"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1038\/s41598-020-65100-2","article-title":"Serum level of HDL particles are independently associated with long-term prognosis in patients with coronary artery disease: the GENES study","volume":"10","author":"T Duparc","year":"2020","journal-title":"Sci Rep"},{"issue":"05","key":"ref20","doi-asserted-by":"crossref","first-page":"e002977","DOI":"10.1161\/JAHA.115.002977","article-title":"Concentration of smaller high-density lipoprotein particle (HDL-P) is inversely correlated with carotid intima media thickening after confounder adjustment: the Multi Ethnic Study of Atherosclerosis (MESA)","volume":"5","author":"D S Kim","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"09","key":"ref21","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/aje\/kwx016","article-title":"Quantitative serum nuclear magnetic resonance metabolomics in large-scale epidemiology: a primer on -omic technologies","volume":"186","author":"P W\u00fcrtz","year":"2017","journal-title":"Am J Epidemiol"},{"issue":"04","key":"ref22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/07853890.2016.1241428","article-title":"Center-based patient care enhances survival of elderly patients suffering from peripheral arterial disease","volume":"49","author":"C H\u00f6baus","year":"2017","journal-title":"Ann Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"33","author":"L Norgren","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"ref24","first-page":"499","article-title":"Surgical treatment of peripheral circulation disorders [in German]","volume":"21","author":"R Fontaine","year":"1954","journal-title":"Helv Chir Acta"},{"issue":"09","key":"ref25","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"A S Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"04","key":"ref26","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/2047487313483600","article-title":"Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials","volume":"20","author":"H Naci","year":"2013","journal-title":"Eur J Prev Cardiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"11122","DOI":"10.1038\/ncomms11122","article-title":"Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA","volume":"7","author":"J Kettunen","year":"2016","journal-title":"Nat Commun"},{"issue":"06","key":"ref28","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jacc.2017.12.006","article-title":"Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke","volume":"71","author":"M V Holmes","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1194\/jlr.M500187-JLR200","article-title":"Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux","volume":"46","author":"B F Asztalos","year":"2005","journal-title":"J Lipid Res"},{"issue":"12","key":"ref30","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1161\/ATVBAHA.109.194555","article-title":"HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis","volume":"29","author":"A Zerrad-Saadi","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"01","key":"ref31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0021-9150(00)00659-6","article-title":"Time sequence of the inhibition of endothelial adhesion molecule expression by reconstituted high density lipoproteins","volume":"157","author":"M A Clay","year":"2001","journal-title":"Atherosclerosis"},{"issue":"03","key":"ref32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/cvr\/cvn120","article-title":"Cytokines and atherosclerosis: a comprehensive review of studies in mice","volume":"79","author":"R Kleemann","year":"2008","journal-title":"Cardiovasc Res"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1373\/clinchem.2017.275636","article-title":"High-density lipoprotein subclasses, coronary artery disease, and cardiovascular mortality","volume":"63","author":"G Silbernagel","year":"2017","journal-title":"Clin Chem"},{"issue":"15","key":"ref34","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.clinbiochem.2016.09.004","article-title":"Utility of high density lipoprotein particle concentration in predicting future major adverse cardiovascular events among patients undergoing angiography","volume":"49","author":"H T May","year":"2016","journal-title":"Clin Biochem"},{"issue":"21","key":"ref35","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1161\/CIRCULATIONAHA.118.035432","article-title":"Lipoprotein particle profiles, standard lipids, and peripheral artery disease incidence","volume":"138","author":"A W Aday","year":"2018","journal-title":"Circulation"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"46642","DOI":"10.1038\/srep46642","article-title":"Serum concentration of HDL particles predicts mortality in acute heart failure patients","volume":"7","author":"I Poto\u010dnjak","year":"2017","journal-title":"Sci Rep"},{"issue":"02","key":"ref37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2018.10.059","article-title":"High-density lipoprotein particle subfractions in heart failure with preserved or reduced ejection fraction","volume":"73","author":"W G Hunter","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"06","key":"ref38","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/9504","article-title":"The intrinsic factor-vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein","volume":"5","author":"R Kozyraki","year":"1999","journal-title":"Nat Med"},{"issue":"06","key":"ref39","doi-asserted-by":"crossref","first-page":"F511","DOI":"10.1152\/ajprenal.00508.2015","article-title":"Increased carbamylation level of HDL in end-stage renal disease: carbamylated-HDL attenuated endothelial cell function","volume":"310","author":"J T Sun","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"14","key":"ref40","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1074\/jbc.C600011200","article-title":"Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I","volume":"281","author":"B Shao","year":"2006","journal-title":"J Biol Chem"},{"issue":"02","key":"ref41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.amjcard.2013.09.006","article-title":"High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromes","volume":"113","author":"A Hafiane","year":"2014","journal-title":"Am J Cardiol"},{"issue":"07","key":"ref42","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/ATVBAHA.111.227181","article-title":"Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia","volume":"31","author":"N Bellanger","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/ATVBAHA.109.201715","article-title":"Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I","volume":"30","author":"E Nob\u00e9court","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"08","key":"ref44","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1007\/s00125-007-0718-9","article-title":"Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties","volume":"50","author":"A Hoang","year":"2007","journal-title":"Diabetologia"},{"issue":"01","key":"ref45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/clinchem\/hvaa252","article-title":"Residual cardiovascular risk at low LDL: remnants, lipoprotein(a), and inflammation","volume":"67","author":"R C Hoogeveen","year":"2021","journal-title":"Clin Chem"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1827-7896.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:01:38Z","timestamp":1664236898000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1827-7896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,18]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,9,26]]},"published-print":{"date-parts":[[2022,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1827-7896","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,18]]},"published":{"date-parts":[[2022,4,18]]}}}